Healthcare / Medical Care FacilitiesNasdaqCM
$19.77
+0.39 (+2.01%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 27% · confianza 25%
FCF escenarios
weak_data · normalized FCF $10.3M · quality 36.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
20/100
D
Piotroski
n/d
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
4/100
SEC 0%
Sin guardar todavía.
Market Cap
$89M
P/E
N/A
•EV/EBITDA
7.6x
↓ROE
-1.6%
↓Gross Margin
13.8%
↓Debt/Equity
2.77
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2025–2025 · 0 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
4.2%
FCF / Net income
-28.74x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $244.5M · net income $-358000.0 · FCF $10.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 |
|---|---|---|
| Income Statement | ||
| Revenue | $244.5M | $244.5M |
| Net Income | $-358000.00 | $-358000.00 |
| EBITDA | $9.6M | $9.6M |
| EPS | -0.18 | -0.18 |
| Gross Margin | 13.8% | 13.8% |
| Operating Margin | 0.1% | 0.1% |
| Net Margin | -0.1% | -0.1% |
| Balance Sheet | ||
| Debt/Equity | 2.77 | 2.77 |
| Current Ratio | 1.07 | 1.07 |
| Cash Flow | ||
| Free Cash Flow | $10.3M | $10.3M |
| Returns | ||
| ROE | -1.6% | -1.6% |
| Valuation | ||
| EV/EBITDA | 7.65 | 7.65 |
| P/B | 1.76 | 1.76 |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+92.9%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → -0.18
Residual
+92.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.